ADAR1 Capital Management, LLC
CIK: 0001940272Latest portfolio: $1.4B · Q4 2025
Holdings
256
Total Value
$1.4B
New Positions
81
Closed Positions
26
Top Holdings
View All 256 Holdings →| # | Stock | Shares | Value | % Portfolio | Change | Type |
|---|---|---|---|---|---|---|
| 1 | ABVXABIVAX SA | 1,317,329 | $177.6M | 12.86% | -33,497 | |
| 2 | PTGXPROTAGONIST THERAPEUTICS INC | 1,049,168 | $91.6M | 6.63% | +60K | |
| 3 | ROIVROIVANT SCIENCES LTD | 3,428,962 | $74.4M | 5.39% | +81K | |
| 4 | IMVTIMMUNOVANT INC | 2,480,968 | $63.1M | 4.57% | +239K | |
| 5 | RNAAVIDITY BIOSCIENCES INC | 546,534 | $39.4M | 2.85% | +493K | |
| 6 | BOXXEA SERIES TRUST | 337,125 | $38.8M | 2.81% | — | |
| 7 | SPYSPDR S&P 500 ETF TR | 54,684 | $37.3M | 2.70% | NEW | |
| 8 | CYTKCYTOKINETICS INC | 540,166 | $34.3M | 2.49% | +21K | |
| 9 | SEPNSEPTERNA INC | 1,157,611 | $32.3M | 2.34% | -18,880 | |
| 10 | I9DNARBUTUS BIOPHARMA CORP | 5,415,109 | $26.0M | 1.89% | +2.5M | |
| 11 | —PERCEPTIVE CAP SOLUTIONS COR | 1,956,720 | $25.5M | 1.85% | +1.2M | |
| 12 | ZLABZAI LAB LTD | 1,246,520 | $22.0M | 1.59% | +378K | |
| 13 | TERNTERNS PHARMACEUTICALS INC | 541,615 | $21.9M | 1.58% | +532K | |
| 14 | CTMXCYTOMX THERAPEUTICS INC | 4,282,769 | $18.2M | 1.32% | NEW | Call |
| 15 | TCE2CELLDEX THERAPEUTICS INC NEW | 646,767 | $17.6M | 1.27% | +537K | |
| 16 | RAPTRAPT THERAPEUTICS INC | 509,679 | $17.3M | 1.25% | +2K | |
| 17 | IKTINHIBIKASE THERAPEUTICS INC | 8,063,949 | $16.5M | 1.20% | +2.8M | |
| 18 | BBIOBRIDGEBIO PHARMA INC | 213,414 | $16.3M | 1.18% | -60,000 | |
| 19 | MNPRMONOPAR THERAPEUTICS INC | 233,908 | $15.3M | 1.11% | +104K | |
| 20 | FULCFULCRUM THERAPEUTICS INC | 1,318,749 | $14.9M | 1.08% | +902K | Call |
| 21 | PCVXVAXCYTE INC | 315,642 | $14.6M | 1.05% | +103K | |
| 22 | CRNXCRINETICS PHARMACEUTICALS IN | 309,368 | $14.4M | 1.04% | +61K | |
| 23 | PRTAPROTHENA CORP PLC | 1,457,764 | $13.9M | 1.01% | -11,334 | |
| 24 | LXEOLEXEO THERAPEUTICS INC | 1,393,161 | $13.8M | 1.00% | -138,792 | |
| 25 | TSHATAYSHA GENE THERAPIES INC | 2,495,809 | $13.7M | 0.99% | -339,871 |
Quarterly Changes
New Positions
Closed Positions
- SPYCLOSED$66.7B
- ETNBGBPCLOSED$31.1B
- CTMXCLOSED$12.9B
- MTSRCLOSED$8.0B
- VRNACLOSED$5.5B
- BBIO 2.25 02/01/29CLOSED$4.4B
- XBICLOSED$4.0B
- MRUSCLOSED$3.1B
- BBIO 2.5 03/15/27CLOSED$2.8B
- ASPCRCLOSED$2.2B
Increased Positions
Sector Breakdown
HealthcareNaN% ($InfinityT)
Financial Services0.0% ($3.880337290123891e+43T)
Unknown0.0% ($2.6046254961756615e+42T)
Technology0.0% ($101.3T)
Consumer Cyclical0.0% ($1.7T)
Industrials0.0% ($66.5B)
Communication Services0.0% ($1.0M)
Real Estate0.0% ($797K)
Filing History
Fund Information
ADAR1 Capital Management, LLC is an institutional investment manager that files 13F reports with the SEC. As of the Q4 2025 filing, the fund reported a portfolio valued at $1.4B across 256 holdings. The largest position is ABIVAX SA (ABVX), representing 12.9% of the portfolio. Compared to the previous quarter, the fund opened 92 new positions and closed 39 positions. 13F filings are required quarterly disclosures that provide transparency into the holdings of institutional investment managers with at least $100 million in qualifying assets.